FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963092329> ?p ?o ?g. }

• W2963092329 endingPage "150" @default.
• W2963092329 startingPage "1" @default.
• W2963092329 abstract "Background People with Parkinson’s disease are twice as likely to experience a fall as a healthy older person, often leading to debilitating effects on confidence, activity levels and quality of life. Objective To estimate the effect of a physiotherapy programme for fall prevention among people with Parkinson’s disease. Design A multicentre, pragmatic, investigator-masked, individually randomised controlled trial (RCT) with prespecified subgroup analyses. Setting Recruitment from NHS hospitals and clinics and community and social services in eight English regions with home-based interventions. Participants A total of 474 people with Parkinson’s disease (i.e. Hoehn and Yahr scale stages 1–4) were recruited: 238 were assigned to a physiotherapy programme and 236 were assigned to usual care. Random allocation was 50 : 50. Interventions All participants received routine care; the usual-care group received an information digital versatile disc (DVD) and a single advice session at trial completion. The intervention group had an individually tailored, progressive, home-based fall avoidance strategy training programme with balance and strengthening exercises: PDSAFE. Main outcome measures The primary outcome was the risk of repeat falling, collected by self-report monthly diaries between 0 and 6 months after randomisation. Secondary outcomes included near-falls, falls efficacy, freezing of gait (FoG), health-related quality of life, and measurements taken using the Mini-Balance Evaluation Systems Test (Mini-BESTest), the Chair Stand Test (CST), the Geriatric Depression Scale, the Physical Activity Scale for the Elderly and the Parkinson’s Disease Questionnaire. Results PDSAFE is the largest RCT of falls management among people with Parkinson’s disease: 541 patients were screened for eligibility. The average age was 72 years, and 266 out of 474 (56%) participants were men. Of the 474 randomised participants, 238 were randomised to the intervention group and 236 were randomised to the control group. No difference in repeat falling within 6 months of randomisation was found [PDSAFE group to control group odds ratio (OR) 1.21, 95% confidence interval (CI) 0.74 to 1.98; p = 0.447]. An analysis of secondary outcomes demonstrated better balance (Mini-BESTest: mean difference 0.95, 95% CI 0.24 to 1.67; p = 0.009), functional strength (CST: p = 0.041) and falls efficacy (Falls Efficacy Scale – International: mean difference 1.6, 95% CI –3.0 to –0.19; p = 0.026) with near-falling significantly reduced with PDSAFE (OR 0.67, 95% CI 0.53 to 0.86; p = 0.001) at 6 months. Prespecified subgroup analysis (i.e. disease severity and FoG) revealed a PDSAFE differing effect; the intervention may be of benefit for people with moderate disease but may increase falling for those in the more severe category, especially those with FoG. Limitations All participants were assessed at primary outcome; only 73% were assessed at 12 months owing to restricted funding. Conclusions PDSAFE was not effective in reducing repeat falling across the range of people with Parkinson’s disease in the trial. Secondary analysis demonstrated that other functional tasks and self-efficacy improved and demonstrated differential patterns of intervention impact in accordance with disease severity and FoG, which supports previous secondary research findings and merits further primary evaluation. Future work Further trials of falls prevention on targeted groups of people with Parkinson’s disease are recommended. Trial registration Current Controlled Trials ISRCTN48152791. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 23, No. 36. See the NIHR Journals Library website for further project information. Sarah E Lamb is funded by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) at Oxford Health NHS Foundation Trust, the NIHR Oxford Biomedical Research Centre at the Oxford University Hospitals NHS Foundation Trust and CLAHRC Oxford. Victoria A Goodwin is supported by the NIHR Collaborations for Leadership in Applied Health Research and Care in the South West Peninsula (PenCLAHRC). Lynn Rochester is supported by the NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The research was also supported by the NIHR Newcastle Clinical Research Facility Infrastructure funding. Helen C Roberts is supported by CLAHRC Wessex and the NIHR Southampton Biomedical Research Centre." @default.
• W2963092329 created "2019-07-30" @default.
• W2963092329 creator A5003487709 @default.
• W2963092329 creator A5004012265 @default.
• W2963092329 creator A5009050493 @default.
• W2963092329 creator A5009655769 @default.
• W2963092329 creator A5010172983 @default.
• W2963092329 creator A5030150280 @default.
• W2963092329 creator A5030612566 @default.
• W2963092329 creator A5034909916 @default.
• W2963092329 creator A5048449023 @default.
• W2963092329 creator A5067755203 @default.
• W2963092329 creator A5068995535 @default.
• W2963092329 creator A5069029982 @default.
• W2963092329 date "2019-07-01" @default.
• W2963092329 modified "2023-10-14" @default.
• W2963092329 title "Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson’s: the PDSAFE RCT" @default.
• W2963092329 cites W1522542721 @default.
• W2963092329 cites W1591586372 @default.
• W2963092329 cites W1766657026 @default.
• W2963092329 cites W1847168837 @default.
• W2963092329 cites W1951248498 @default.
• W2963092329 cites W1971454445 @default.
• W2963092329 cites W1975293681 @default.
• W2963092329 cites W1979290264 @default.
• W2963092329 cites W1984221973 @default.
• W2963092329 cites W1988718495 @default.
• W2963092329 cites W1990533982 @default.
• W2963092329 cites W2003759089 @default.
• W2963092329 cites W2020716656 @default.
• W2963092329 cites W2027448975 @default.
• W2963092329 cites W2030730789 @default.
• W2963092329 cites W2034541979 @default.
• W2963092329 cites W2036641986 @default.
• W2963092329 cites W2037163995 @default.
• W2963092329 cites W2046634204 @default.
• W2963092329 cites W2057105744 @default.
• W2963092329 cites W2059341465 @default.
• W2963092329 cites W2064658437 @default.
• W2963092329 cites W2064996887 @default.
• W2963092329 cites W2068867902 @default.
• W2963092329 cites W2075141693 @default.
• W2963092329 cites W2082512168 @default.
• W2963092329 cites W2085308059 @default.
• W2963092329 cites W2095674834 @default.
• W2963092329 cites W2100959123 @default.
• W2963092329 cites W2101064932 @default.
• W2963092329 cites W2105182594 @default.
• W2963092329 cites W2108504020 @default.
• W2963092329 cites W2114022278 @default.
• W2963092329 cites W2118249259 @default.
• W2963092329 cites W2124808208 @default.
• W2963092329 cites W2128077231 @default.
• W2963092329 cites W2128290688 @default.
• W2963092329 cites W2128450027 @default.
• W2963092329 cites W2132519139 @default.
• W2963092329 cites W2135305172 @default.
• W2963092329 cites W2141995258 @default.
• W2963092329 cites W2145362071 @default.
• W2963092329 cites W2145555293 @default.
• W2963092329 cites W2149659204 @default.
• W2963092329 cites W2150072209 @default.
• W2963092329 cites W2152478041 @default.
• W2963092329 cites W2154695042 @default.
• W2963092329 cites W2159480252 @default.
• W2963092329 cites W2165758561 @default.
• W2963092329 cites W2169996686 @default.
• W2963092329 cites W2174012530 @default.
• W2963092329 cites W2180451604 @default.
• W2963092329 cites W2265186954 @default.
• W2963092329 cites W2311247693 @default.
• W2963092329 cites W2336442998 @default.
• W2963092329 cites W2517578150 @default.
• W2963092329 cites W2517633671 @default.
• W2963092329 cites W2600131113 @default.
• W2963092329 cites W2749232681 @default.
• W2963092329 cites W2753713511 @default.
• W2963092329 cites W2757231908 @default.
• W2963092329 cites W2802629757 @default.
• W2963092329 cites W2932221571 @default.
• W2963092329 cites W3021048901 @default.
• W2963092329 cites W4210487975 @default.
• W2963092329 cites W4248854933 @default.
• W2963092329 cites W591419157 @default.
• W2963092329 doi "https://doi.org/10.3310/hta23360" @default.
• W2963092329 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6680369" @default.
• W2963092329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31339100" @default.
• W2963092329 hasPublicationYear "2019" @default.
• W2963092329 type Work @default.
• W2963092329 sameAs 2963092329 @default.
• W2963092329 citedByCount "37" @default.
• W2963092329 countsByYear W29630923292020 @default.
• W2963092329 countsByYear W29630923292021 @default.
• W2963092329 countsByYear W29630923292022 @default.
• W2963092329 countsByYear W29630923292023 @default.
• W2963092329 crossrefType "journal-article" @default.
• W2963092329 hasAuthorship W2963092329A5003487709 @default.
• W2963092329 hasAuthorship W2963092329A5004012265 @default.

• next